Plainsboro, NJ, United States of America

Kevin Douglas Kreutter

This inventor holds 42 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 20 EPO patents, primarily in Kinase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Johnson & Johnson Pharmaceuticals Research & Development, L.l.c., Nimbus Artemis, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Douglas Kreutter. Retrieved from https://idiyas.com/inventor/kevin-douglas-kreutter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 42 (Patent Applications = 5)

% Patents Active = 66.7

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 20 (Patent Applications = 18)

Average Co-Inventor Count = 10.0

ph-index = 6

Forward Citations = 158(Granted Patents)

Location History:

Plainsboro, NJ (US) (2007 - 2024)
Arlington, MA (US) (2019 - 2024)

Company Filing History:

39 out of 2,103

Janssen Pharmaceutica Nv

patents

1 out of 1

Johnson & Johnson Pharmaceuticals Research & Development, L.l.c.

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

JAK Family Kinase

Bruton's Tyrosine Kinase

MALT1 Inhibitors

KEAP1-Nrf2 Interaction

Pyrazole Derivatives

ACLY Inhibitors

Glucagon Receptor Antagonists

RORgammat Modulators

Thrombin Modulators

Small Molecule Inhibitors

Quinolinyl Modulators

Phenyl Linked Modulators

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516038 - Inhibitors of antigen presentation by HLA-DR (2026-01-06),

2. 12331046 - CTPS1 inhibitors and uses thereof (2025-06-17),

3. 12202831 - Small molecule inhibitors of the JAK family of kinases (2025-01-21),

4. 12077521 - Pyrazole derivatives as MALT1 inhibitors (2024-09-03),

5. 12065446 - Inhibitors of Bruton's tyrosine kinase and method of their use (2024-08-20),

6. 11897900 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2024-02-13),

7. 11827638 - Imidazopyrrolopyridine as inhibitors of the JAK family of kinases (2023-11-28),

8. 11492341 - ACLY inhibitors and uses thereof (2022-11-08),

9. 11427601 - Inhibitors of KEAP1-Nrf2 protein-protein interaction (2022-08-30),

10. 11319329 - Inhibitors of Bruton's tyrosine kinase and methods of their use (2022-05-03),

11. 11254673 - Small molecule inhibitors of NF-κB inducing kinase (2022-02-22),

12. 11059823 - Small molecule inhibitors of the JAK family of kinases (2021-07-13),

13. 11040031 - Pyrazole derivatives as MALT1 inhibitors (2021-06-22),

14. 10981911 - Imidazopyrrolopyridine as inhibitors of the JAK family of kinases (2021-04-20),

15. 10954214 - Pyrazole derivatives as MALT1 inhibitors (2021-03-23),

Title: The Innovative Mind of Kevin Douglas Kreutter

Introduction:

Kevin Douglas Kreutter, a talented inventor hailing from Plainsboro, NJ, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents:

Kevin Douglas Kreutter holds several patents in various fields, including telecommunications, renewable energy, and medical devices. His most recent patent focuses on a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights:

With a career spanning over two decades, Kevin Douglas Kreutter has worked for renowned tech companies, leading research institutions, and universities. His expertise in developing cutting-edge solutions has earned him a stellar reputation in the industry.

Collaborations:

Throughout his career, Kevin Douglas Kreutter has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion:

In conclusion, Kevin Douglas Kreutter's passion for innovation and his relentless pursuit of excellence have solidified his position as a prominent figure in the world of inventions. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.